These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29153094)

  • 61. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Soma LA; Craig FE; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015.
    Ko BS; Chen LJ; Huang HH; Chen HM; Hsiao FY
    Int J Clin Pract; 2021 Aug; 75(8):e14258. PubMed ID: 33884738
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma.
    Plander M; Ugocsai P; Seegers S; Orsó E; Reichle A; Schmitz G; Hofstädter F; Brockhoff G
    Ann Hematol; 2011 Dec; 90(12):1381-90. PubMed ID: 21465189
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
    Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
    Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Leukemia cutis coexisting with dermatofibroma as the initial presentation of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Maughan C; Kolker S; Markus B; Young J
    Am J Dermatopathol; 2014 Jan; 36(1):e14-5. PubMed ID: 23974225
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation.
    Hess B; Kalmuk J; Znoyko I; Schandl CA; Wagner-Johnston N; Mazzoni S; Hendrickson L; Chiad Z; Greenwell IB; Wolff DJ
    Cancer Genet; 2022 Jan; 260-261():18-22. PubMed ID: 34808593
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
    Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
    Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein.
    Yin CC; Lin P; Carney DA; Handy BC; Rassidakis GZ; Admirand JH; Keating MJ; Medeiros LJ
    Am J Clin Pathol; 2005 Apr; 123(4):594-602. PubMed ID: 15743747
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CXCR4 overexpression in chronic lymphocytic leukemia associates with poorer prognosis: A prospective, single-center, observational study.
    Xue X; Wen Z; Zhang X; Yang Y; Li Y; Liao R; Zheng Q; Fu Y; Liu Y; Liao H
    Genes Immun; 2024 Apr; 25(2):117-123. PubMed ID: 38366101
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia.
    Dal Bo M; Tissino E; Benedetti D; Caldana C; Bomben R; Poeta GD; Gaidano G; Rossi FM; Bulian P; Zucchetto A; Gattei V
    Curr Cancer Drug Targets; 2016; 16(8):659-668. PubMed ID: 27514846
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chronic lymphocytic leukaemia.
    Scarfò L; Ferreri AJ; Ghia P
    Crit Rev Oncol Hematol; 2016 Aug; 104():169-82. PubMed ID: 27370174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Possible role of CD22, CD79b and CD20 expression in distinguishing small lymphocytic lymphoma from chronic lymphocytic leukemia.
    Jovanovic D; Djurdjevic P; Andjelkovic N; Zivic L
    Contemp Oncol (Pozn); 2014; 18(1):29-33. PubMed ID: 24876818
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia.
    Bagacean C; Iuga CA; Bordron A; Tempescul A; Pralea IE; Bernard D; Cornen M; Bergot T; Le Dantec C; Brooks W; Saad H; Ianotto JC; Pers JO; Zdrenghea M; Berthou C; Renaudineau Y
    J Leukoc Biol; 2022 Feb; 111(2):313-325. PubMed ID: 34288092
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adhesion molecules expression in CLL: Potential impact on clinical and hematological parameters.
    Kamel AM; El-Sharkawy NM; Osman RA; Abd El-Fattah EK; El-Noshokaty E; Abd El-Hamid T; Kandeel EZ
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):31-7. PubMed ID: 26873628
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dietary factors and risk of chronic lymphocytic leukemia and small lymphocytic lymphoma: a pooled analysis of two prospective studies.
    Tsai HT; Cross AJ; Graubard BI; Oken M; Schatzkin A; Caporaso NE
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2680-4. PubMed ID: 20929883
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protein profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Mactier S; Armacki N; Giles Best O; Belov L; Kaufman KL; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2016 May; 57(5):1033-43. PubMed ID: 26422656
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene.
    Gibson SE; Leeman-Neill RJ; Jain S; Piao W; Cieply KM; Swerdlow SH
    Br J Haematol; 2016 Oct; 175(1):173-5. PubMed ID: 26568397
    [No Abstract]   [Full Text] [Related]  

  • 80. Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high-risk features and reduced treatment-free-intervals.
    Elizabeth S; Aidan K; David OB; Deirdre W; Sarah B; Emer A; Kanthi P; Crotty GM; Aileen W; Michelle C; Ruth C; Hilary O; Ashique K; Bacon CL; Emily S; McElligott AM; Fiona Q; Elisabeth V; Carmel W
    Eur J Haematol; 2022 Nov; 109(5):441-446. PubMed ID: 35776688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.